stockrowAdaptive Biotechnologies Corporation (ADPT) vs Veracyte, Inc. (VCYT)
- Adaptive Biotechnologies Corporation ADPT 26.96 +0.94%
- Veracyte, Inc. VCYT 24.11 −54.09%
Adaptive Biotechnologies Corporation and Veracyte, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.3B against $1.9B — 2.2× the size. Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 17.9% against 17.5%. Veracyte, Inc. has the higher net margin (21.8% vs −23.7%) and the higher return on invested capital (4.33% vs 0.00%). Across the 17 metrics below, Veracyte, Inc. leads on 15 and Adaptive Biotechnologies Corporation on 2.
Valuation
Profitability
| Metric | ADPT | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 71.98% | 48.32% |
| Operating margin | (16.18%) | 17.08% | (5.68%) |
| Net margin | (23.66%) | 21.80% | (4.10%) |
| Free cash flow margin | (2.96%) | 27.84% | 0.00% |
| Return on equity | (36.34%) | 9.43% | 0.00% |
| Return on assets | (12.02%) | 8.63% | (6.05%) |
| Return on invested capital | 0.00% | 4.33% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack